Large drugmakers with the lowest price to sales ratio

Ranked

157

of 412 large drugmakers we cover

Median

4.7×

Lowest

0.0×

SBFM

Range

0.0× to 83.3×

#	Company	P/S	Net margin	Revenue growth (TTM)	Market cap
1	SBFMSunshine Biopharma	0.0×	−16.5%	−2.7%	$581.6K
2	JAGXJaguar Health	0.0×	n/m	+135.5%	$702.9K
3	KPTIKaryopharm Therapeutics	0.1×	n/m	+6.8%	$11.7M
4	BHCBausch Health Companies	0.2×	−10.1%	+10.1%	$2.4B
5	BFRIBiofrontera	0.3×	−13.8%	+17.8%	$11.7M
6	ORGOOrganogenesis	0.3×	−18.4%	+6.5%	$127.8M
7	HCWBHCW Biologics	0.3×	−83.0%	n/m	$2.1M
8	AYTUAytu Biopharma	0.4×	−24.8%	−13.3%	$20.6M
9	HRTXHeron Therapeutics	0.4×	−22.5%	+1.0%	$57.5M
10	LFVNLifevantage	0.4×	2.8%	−20.1%	$73.4M
11	RMTIRockwell Medical	0.4×	−7.3%	−21.1%	$28M
12	EBSEmergent BioSolutions	0.4×	−23.0%	−9.6%	$319.4M
13	NATRNatures Sunshine Products	0.4×	3.7%	+6.8%	$213.8M
14	PRGOPERRIGO	0.5×	−41.9%	−4.2%	$2.2B
15	OGNOrganon	0.6×	3.4%	−2.5%	$3.6B
16	XLOXilio Therapeutics	0.7×	n/m	n/m	$43.8M
17	AKBAAkebia Therapeutics	0.7×	−13.5%	+7.5%	$157.1M
18	ELABPMGC	0.8×	n/m	n/m	$2.2M
19	MGNXMacrogenics	0.9×	−8.7%	+11.7%	$143.3M
20	COLLCollegium Pharmaceutical	0.9×	5.9%	+14.3%	$747.5M
21	SRPTSarepta Therapeutics	0.9×	−6.9%	−20.4%	$1.9B
22	PAHCPhibro Animal Health	1.0×	6.6%	+17.1%	$1.6B
23	GOSSGossamer Bio	1.1×	n/m	+32.4%	$58.7M
24	VNDAVanda Pharmaceuticals	1.1×	n/m	+6.0%	$242.5M
25	XBIOXenetic Biosciences	1.2×	−75.9%	+33.3%	$4M
26	CRMDCorMedix	1.3×	40.5%	+280.5%	$611.9M
27	AMRNAmarin Corp Plc	1.3×	−14.6%	−15.1%	$249M
28	SPROSpero Therapeutics	1.4×	15.7%	−3.3%	$64.6M
29	EOLSEvolus	1.5×	−10.8%	+13.9%	$463M
30	AMPHAmphastar Pharmaceuticals	1.5×	10.8%	+1.0%	$1.1B
31	IRWDIronwood Pharmaceuticals	1.5×	33.4%	+26.2%	$571.7M
32	ARVNArvinas	1.5×	2.9%	−15.0%	$477.3M
33	CELUCelularity	1.7×	n/m	−58.1%	$31.7M
34	ARDXArdelyx	1.7×	−12.4%	+16.8%	$767.5M
35	ANIPANI Pharmaceuticals	1.7×	11.1%	+30.9%	$1.7B
36	PHATPhathom Pharmaceuticals	1.9×	−41.3%	+110.2%	$464.4M
37	PCRXPacira BioSciences	1.9×	2.0%	+5.7%	$1.5B
38	SCYXScynexis	2.0×	−53.3%	n/m	$37.7M
39	VRCAVerrica Pharmaceuticals	2.0×	n/m	+106.2%	$60.6M
40	ENSCEnsysce Biosciences	2.0×	n/m	−39.3%	$9.2M
41	PBHPrestige Consumer Healthcare	2.0×	15.6%	−1.4%	$2.3B
42	OPKOpko Health	2.1×	−12.4%	−11.5%	$1.2B
43	DERMJourney Medical	2.1×	−9.0%	+20.9%	$141.7M
44	AMRXAmneal Pharmaceuticals	2.1×	5.0%	+9.3%	$6.5B
45	RAREUltragenyx Pharmaceutical	2.2×	−81.7%	+17.4%	$1.5B
46	HRMYHarmony Biosciences	2.2×	18.9%	+24.3%	$2.1B
47	ELANElanco Animal Health	2.2×	−4.0%	+12.0%	$11.3B
48	ADCTADC Therapeutics SA	2.3×	n/m	+3.0%	$183.8M
49	PBYIPuma Biotechnology	2.5×	11.6%	−2.9%	$568.9M
50	BMYBristol-Myers Squibb	2.6×	18.9%	+3.1%	$125.6B
51	BOLTBolt Biotherapeutics	2.6×	n/m	+12.8%	$12.1M
52	MNKDMannkind	2.6×	−11.1%	+30.5%	$1B
53	PFEPfizer	2.7×	6.8%	−0.2%	$171.2B
54	VTVTvTv Therapeutics	2.7×	−12.9%	n/m	$101M
55	SXTP60 Degrees Pharmaceuticals	2.8×	n/m	+73.2%	$3.1M
56	LABStandard Biotools	2.8×	n/m	−23.6%	$237.7M
57	SUPNSupernus Pharmaceuticals	2.8×	−13.2%	+24.9%	$2.4B
58	ACADAcadia Pharmaceuticals	3.0×	33.4%	+11.8%	$3.4B
59	JAZZJazz Pharmaceuticals	3.0×	20.4%	+12.6%	$13.9B
60	TNXPTonix Pharmaceuticals	3.0×	n/m	+196.0%	$88.7M
61	INDVIndivior Pharmaceuticals	3.1×	26.7%	+13.5%	$4.1B
62	BMRNBiomarin Pharmaceutical	3.2×	2.1%	+11.2%	$10.8B
63	FHTXFoghorn Therapeutics	3.2×	n/m	+52.0%	$118.8M
64	RIGLRigel Pharmaceuticals	3.2×	n/m	+3.3%	$899.1M
65	INVAInnoviva	3.4×	81.2%	+18.8%	$1.5B
66	SPRYARS Pharmaceuticals	3.4×	n/m	+4.1%	$400.8M
67	GERNGeron	3.5×	−33.1%	+24.4%	$719.6M
68	CUECue Biopharma	3.6×	n/m	n/m	$135.6M
69	BIIBBiogen	3.7×	8.3%	+0.3%	$37B
70	HROWHarrow	3.9×	−13.5%	+21.1%	$1.1B
71	NRIXNurix Therapeutics	3.9×	42.0%	n/m	$2.8B
72	BCYCBicycle Therapeutics	4.1×	n/m	+217.4%	$248.5M
73	CPIXCumberland Pharmaceuticals	4.1×	−34.9%	−1.1%	$127.2M
74	SIGASiga Technologies	4.2×	−5.2%	−70.1%	$224.2M
75	ZVRAZevra Therapeutics	4.3×	42.8%	+119.4%	$582.6M
76	LGVNLongeveron	4.3×	n/m	−42.7%	$5.1M
77	ALKSAlkermes plc.	4.4×	4.0%	+10.8%	$7.3B
78	ABUSArbutus Biopharma	4.6×	84.2%	n/m	$831M
79	SNDXSyndax Pharmaceuticals	4.7×	−87.5%	+222.7%	$1.2B
80	CYRXCryoport	4.9×	−20.1%	+12.1%	$910.7M
81	PTCTPTC Therapeutics	5.0×	−3.8%	−42.8%	$5.1B
82	ENTAEnanta Pharmaceuticals	5.2×	−96.9%	+0.7%	$339M
83	MRKMerck	5.4×	4.8%	+4.6%	$358.4B
84	ASMBAssembly Biosciences	5.4×	−0.1%	+125.1%	$404M
85	GYREGyre Therapeutics	5.5×	−15.5%	+13.5%	$652.3M
86	XERSXeris Biopharma	5.5×	−5.1%	+36.3%	$1.9B
87	ZLABZai Lab	6.0×	−41.9%	+5.1%	$2.7B
88	AMGNAmgen	6.2×	23.0%	+9.1%	$237.5B
89	GILDGilead Sciences	6.4×	−10.6%	+5.5%	$193.5B
90	TXMDTherapeuticsMD	6.4×	−6.6%	+27.8%	$20.8M
91	JNJJohnson & Johnson	6.4×	n/m	+7.8%	$635.8B
92	SDGRSchrodinger	6.9×	−21.0%	+8.9%	$1.8B
93	KNSAKiniksa Pharmaceuticals International	7.1×	9.6%	+58.9%	$6B
94	AUPHAurinia Pharmaceuticals	7.2×	n/m	+19.8%	$2.2B
95	CPHIChina Pharma	7.2×	n/m	−11.0%	$28.3M
96	LPCNLipocine	7.6×	n/m	−62.7%	$11.9M
97	PRTAProthena Corp Public	7.7×	−80.7%	n/m	$421M
98	MDGLMadrigal Pharmaceuticals	7.8×	−25.3%	+149.0%	$10B
99	ABBVAbbVie	7.8×	9.8%	+10.4%	$504.8B
100	TVTXTravere Therapeutics	8.0×	−7.4%	+77.1%	$4.7B

The first 100 of 157.

Not ranked: 91 with not a meaningful number, 62 with a quarter missing, 11 with no price to sales (not meaningful for banks and some insurers), 8 with a value too high to mean anything, 5 with a value above 100× (too small a base to compare). 78 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.